230 related articles for article (PubMed ID: 19299559)
1. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.
Yang Z; MacQuarrie KL; Analau E; Tyler AE; Dilworth FJ; Cao Y; Diede SJ; Tapscott SJ
Genes Dev; 2009 Mar; 23(6):694-707. PubMed ID: 19299559
[TBL] [Abstract][Full Text] [Related]
2. Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors.
MacQuarrie KL; Yao Z; Fong AP; Diede SJ; Rudzinski ER; Hawkins DS; Tapscott SJ
Mol Cell Biol; 2013 Feb; 33(4):773-84. PubMed ID: 23230269
[TBL] [Abstract][Full Text] [Related]
3. Myogenic basic helix-loop-helix proteins regulate the expression of peroxisomal proliferator activated receptor-gamma coactivator-1alpha.
Chang JH; Lin KH; Shih CH; Chang YJ; Chi HC; Chen SL
Endocrinology; 2006 Jun; 147(6):3093-106. PubMed ID: 16527841
[TBL] [Abstract][Full Text] [Related]
4. Bakuchiol augments MyoD activation leading to enhanced myoblast differentiation.
Lee SJ; Yoo M; Go GY; Kim DH; Choi H; Leem YE; Kim YK; Seo DW; Ryu JH; Kang JS; Bae GU
Chem Biol Interact; 2016 Mar; 248():60-7. PubMed ID: 26902638
[TBL] [Abstract][Full Text] [Related]
5. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
6. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of myoD.
Lemercier C; To RQ; Carrasco RA; Konieczny SF
EMBO J; 1998 Mar; 17(5):1412-22. PubMed ID: 9482738
[TBL] [Abstract][Full Text] [Related]
7. MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions.
Ishibashi J; Perry RL; Asakura A; Rudnicki MA
J Cell Biol; 2005 Nov; 171(3):471-82. PubMed ID: 16275751
[TBL] [Abstract][Full Text] [Related]
8. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
9. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
Sirri V; Leibovitch MP; Leibovitch SA
Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
[TBL] [Abstract][Full Text] [Related]
10. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis.
Tapscott SJ; Thayer MJ; Weintraub H
Science; 1993 Mar; 259(5100):1450-3. PubMed ID: 8383879
[TBL] [Abstract][Full Text] [Related]
11. [New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?].
Tintignac LA; Leibovitch MP; Leibovitch SA
Bull Cancer; 2001 Jun; 88(6):545-8. PubMed ID: 11459700
[TBL] [Abstract][Full Text] [Related]
12. E2A protein degradation by the ubiquitin-proteasome system is stage-dependent during muscle differentiation.
Sun L; Trausch-Azar JS; Ciechanover A; Schwartz AL
Oncogene; 2007 Jan; 26(3):441-8. PubMed ID: 16909127
[TBL] [Abstract][Full Text] [Related]
13. The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation.
Gerber AN; Wilson CW; Li YJ; Chuang PT
Oncogene; 2007 Feb; 26(8):1122-36. PubMed ID: 16964293
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation.
Di Carlo A; De Mori R; Martelli F; Pompilio G; Capogrossi MC; Germani A
J Biol Chem; 2004 Apr; 279(16):16332-8. PubMed ID: 14754880
[TBL] [Abstract][Full Text] [Related]
15. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage.
Montarras D; Aurade F; Johnson T; IIan J; Gros F; Pinset C
J Cell Sci; 1996 Mar; 109 ( Pt 3)():551-60. PubMed ID: 8907701
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors.
Anand G; Shapiro DN; Dickman PS; Prochownik EV
J Clin Invest; 1994 Jan; 93(1):5-9. PubMed ID: 8282820
[TBL] [Abstract][Full Text] [Related]
17. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47.
Petropoulos H; Skerjanc IS
J Biol Chem; 2000 Aug; 275(33):25095-101. PubMed ID: 10833525
[TBL] [Abstract][Full Text] [Related]
19. Calcium regulation of myogenesis by differential calmodulin inhibition of basic helix-loop-helix transcription factors.
Hauser J; Saarikettu J; Grundström T
Mol Biol Cell; 2008 Jun; 19(6):2509-19. PubMed ID: 18353974
[TBL] [Abstract][Full Text] [Related]
20. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.
Lenormand JL; Benayoun B; Guillier M; Vandromme M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1997 Feb; 17(2):584-93. PubMed ID: 9001211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
